Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Am J Surg. 2021 Feb 1;222(4):861–866. doi: 10.1016/j.amjsurg.2021.01.037

Table 3.

Survival estimates in ten-year intervals for the overall cohort and each histological subtype.

Histological Subtype Time Interval (years) Survival Probability 95% CI
Overall 10 79% 74–85%
20 63% 55–71%
30 60% 50–68%
40 31% 18–46%
Mucoepidermoid 10 84% 63–94%
20 62% 32–81%
30 62% 32–81%
Neuroendocrine 10 89% 82–94%
20 71% 59–80%
30 67% 55–77%
Squamous 10 NR
20 NR
30 NR
Adenocarcinoma 10 88% 66–96%
20 58% 9–89%
30 58% 9–89%
Blastoma 10 62% 45–75%
20 41% 10–71%
30 NR
Sarcoma 10 77% 56–89%
20 77% 56–89%
30 77% 56–89%
*

CI, confidence interval; NR = no patients under observation at this time.